Literature DB >> 26296571

Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk.

Brent Korba1,2, Kirti Shetty3, Alexei Medvedev1, Prasanth Viswanathan1, Rency Varghese4, Bin Zhou4, Rabindra Roy4, Kepher Makambi5, Habtom Ressom4, Christopher A Loffredo5,4.   

Abstract

Specific sequence changes in codons 70 and 91 of the hepatitis C virus genotype 1b (HCV GT1b) core gene have been associated with increased risk of hepatocellular carcinoma (HCC). Essentially all previous studies were conducted in Asian populations with a wide range of liver disease, and none were conducted specifically in GT1a-infected individuals. We conducted a pilot study in a multiethnic population in the USA with HCV-related cirrhosis to determine if this association extended to GT1a-infected individuals and to determine if other sequence changes in the HCV core gene were associated with HCC risk. HCV core gene sequences from sera of 90 GT1 HCV carriers with cirrhosis (42 with HCC) were analysed using standard RT-PCR-based procedures. Nucleotide sequence data were compared with reference sequences available from GenBank. The frequency of sequence changes in codon 91 was not statistically different between HCC (7/19) and non-HCC (11/22) GT1b carriers. In GT1a carriers, sequence changes in codon 91 were observed less often than in GT1b carriers but were not observed in non-HCC subjects (4/23 vs 0/26, P = 0.03, Fisher's exact test). Sequence changes in codon 70 were not distributed differently between HCC and non-HCC GT1a and 1b carriers. Most importantly, for GT1a carriers, a panel of specific nucleotide changes in other codons was collectively present in all subjects with HCC, but not in any of the non-HCC patients. The utility of this test panel for early detection of HCC in GT1a-infected individuals needs to be assessed in larger populations, including longitudinal studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26296571      PMCID: PMC4857454          DOI: 10.1099/jgv.0.000219

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  32 in total

1.  Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.

Authors:  Suguru Ogura; Norio Akuta; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Masahiro Kobayashi; Fumitaka Suzuki; Yoshiyuki Suzuki; Mariko Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  Intervirology       Date:  2009-06-17       Impact factor: 1.763

Review 2.  Hepatocellular carcinoma--epidemiological trends and risk factors.

Authors:  Kerstin Schütte; Jan Bornschein; Peter Malfertheiner
Journal:  Dig Dis       Date:  2009-06-22       Impact factor: 2.404

3.  Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein.

Authors:  N Delhem; A Sabile; R Gajardo; P Podevin; A Abadie; M A Blaton; D Kremsdorf; L Beretta; C Brechot
Journal:  Oncogene       Date:  2001-09-13       Impact factor: 9.867

4.  Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.

Authors:  Mohammad Asim; Abdul Malik; Manash P Sarma; Sunil K Polipalli; Nargis Begum; Istaq Ahmad; Luqman A Khan; S A Husain; Naseem Akhtar; Sajid Husain; L Thayumanavan; Rajiv Singla; P Kar
Journal:  J Med Virol       Date:  2010-07       Impact factor: 2.327

5.  Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region.

Authors:  Shahjalal S Alam; Takashi Nakamura; Atsushi Naganuma; Akito Nozaki; Kazuhiro Nouso; Hiroyuki Shimomura; Nobuyuki Kato
Journal:  Acta Med Okayama       Date:  2002-06       Impact factor: 0.892

6.  Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma.

Authors:  M S De Mitri; L Mele; C H Chen; A Piccinini; R Chianese; A D'Errico; A Alberti; E Pisi
Journal:  J Hepatol       Date:  1998-12       Impact factor: 25.083

7.  Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.

Authors:  Satoshi Ogata; Motoko Nagano-Fujii; Yonson Ku; Seitetsu Yoon; Hak Hotta
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

8.  Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms.

Authors:  Francis J Eng; Jose L Walewski; Arielle L Klepper; Sarah L Fishman; Suresh M Desai; Laura K McMullan; Matthew J Evans; Charles M Rice; Andrea D Branch
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

9.  Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma.

Authors:  Mohamed Abdel-Hamid; Mai El-Daly; Vilma Molnegren; Sherif El-Kafrawy; Sohair Abdel-Latif; Gamal Esmat; G Thomas Strickland; Christopher Loffredo; Jan Albert; Anders Widell
Journal:  J Gen Virol       Date:  2007-05       Impact factor: 3.891

10.  Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection.

Authors:  Erik Alestig; Birgitta Arnholm; Anders Eilard; Martin Lagging; Staffan Nilsson; Gunnar Norkrans; Thomas Wahlberg; Rune Wejstål; Johan Westin; Magnus Lindh
Journal:  BMC Infect Dis       Date:  2011-05-12       Impact factor: 3.090

View more
  3 in total

1.  Subgenotyping and genetic variability of hepatitis C virus in Palestine.

Authors:  Sahar Rayan Da'as; Maysa Azzeh
Journal:  PLoS One       Date:  2019-10-07       Impact factor: 3.240

2.  Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.

Authors:  Cristina Di Poto; Shisi He; Rency S Varghese; Yi Zhao; Alessia Ferrarini; Shan Su; Abdullah Karabala; Mesfin Redi; Hassen Mamo; Amol S Rangnekar; Thomas M Fishbein; Alexander H Kroemer; Mahlet G Tadesse; Rabindra Roy; Zaki A Sherif; Deepak Kumar; Habtom W Ressom
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

Review 3.  Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.

Authors:  C Nelson Hayes; Peiyi Zhang; Yizhou Zhang; Kazuaki Chayama
Journal:  Viruses       Date:  2018-09-28       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.